No Means No, US FDA Advises 503A Compounding Pharmacies

The Pharmacies Must Honor 503A Bulks List Denials, But Can Appeal Them

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".